Human immunoglobulin G1 (Hu IgG1) ELISA quantifies Hu IgG1 in human serum or plasma. The dosage will only recognize natural and recombinant human IgG1. Principle of the L-ELISA solid phase sandwich method of l-IgG1...
Human immunoglobulin G1 (Hu IgG1) ELISA quantifies Hu IgG1 in human serum or plasma. The dosage will only recognize natural and recombinant human IgG1. L-ELISA solid phase sandwich principle of human IgG1 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
L-isotype of a primary antibody and the application in which it is used may cause background staining. Background noise of primary antibodies can be caused by binding to Fc receptors on target cells; by non-specific interactions with cellular proteins, carbohydrates and lipids; or by cell autofluorescence. The d-isotype control antibodies can act as negative controls to help differentiate the non-specific background signal from the specific antibody signal, as they have no specific characteristics relevant to a target antigen. Although the most common use of d-isotype controls is in flow cytometry, they are useful in other applications such as chromatin immunoprecipitation (ChIP), immunohistochemistry and gel displacement. The d-isotype controls should correspond to the primary antibody species and l-isotype so that the specific level of staining by the primary antibody can be determined accurately. In case of use of directly marked primary antibodies, the d-isotype control works better if it is combined with the same marking as the test antibody.
Sensitivity
Sensitivity of the dosage: 0.02 ng.
Measurement range
Dose range: 0.13-4.0 ng/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation in intradose 4.8%, interdose 4.1%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15501627 |
| Specifications |
| Accession number | P16070 |
| Dose range | 0.13-4.0 ng/ml |
| Sensitivity of the dosage | 0.02 ng |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Amniotic liquid, Serum, Surnatant, Supernatant, Urine |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 960 |
| Gene symbol(s) | CDW44,CSPG8,ECMR-III,HCELL,HUTCH-I,IN,LHR,MC56,MDU2,MDU3,MIC4,Pgp1 |
| Coefficient of inter-dose variation | 4.1% |
| Coefficient of intra-dose variation | 4.8% |
| Contents of kits | 96-well pre-coated plate, Stalion, Sample thinner, Dose buffer concentrate, HRP-conjugated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Amniotic liquid, 20 μl; plasma, 10 μl; serum, 10 μl; supernatant, 20 μl; urine, 10 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS2092 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.